Most Recent Posts
Biopharmaceutical research companies have long supported efforts like Global Health Progress to identify global health challenges and find solutions.
We'd like to give you a heads up that tomorrow, October 15, kicks off the 2012 open enrollment period for Medicare Part D. This marks the time when eligible beneficiaries can sign up for Medicare prescription drug coverage - Part D - for the first time or to switch to a plan that better meets their needs. This year the open enrollment period goes through December 7.
Our digital wizards have created another great video, this one about the more than 900 new target="_blank">biologic medicines that are currently in development to treat more than 100 diseases. It features both researchers - including the chief medical officer of Novo Nordisk, Dr.
The Wall Street Journal's Laura Landro wrote today about how patients can benefit from programs that encourage improved adherence to needed medicines.
Every day at PhRMA, we work to support our member companies, whose employees are dedicated to bringing new medicines to the patients who need them.